JPRN-UMIN000012533已完成未知
The effect of anagliptin on blood glucose and lipid levels in type 2 diabetes mellius - The hypoglycemic and lipidemic effect of anagliptin in type 2 diabetes mellius
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Allergy for vildagliptin, linagliptin, repaglinide and glimepiride severe infection, before operation, severe trauma 2)severe ketosis, diabetic coma within 6 months 3)severe hepatic dysfunction or severe renal dysfunction (SCr:more than 2.0mg/dl or eGFR less than 30) 4)pregnacy 5)Patients judged by the investigator to be ineligible for some other reason
研究者
相似试验
已完成
不适用
The effect of anagliptin on blood glucose and serum lipids in Patients with type 2 diabetes mellitusType 2 diabetes mellitusJPRN-UMIN000030532Japan Community Health care Organization, Yokohama Hodogaya Central Hospital40
已完成
不适用
Study of the effect of anagliptin on glucose and lipid metabolism abnormality after the test meal loading.JPRN-UMIN000011424Kanazawa Medical University10
已完成
不适用
Effect of anagliptin on lipid profile in type 2 diabetic patients with hyperlipidemiaType 2 diabetesJPRN-UMIN000013878Yokohama City University Hospital30
已完成
不适用
Effect of anagliptin on plasma glucagon levels determined by LC-MS/MS in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000028293St. Marianna University School of Medicine24
已完成
不适用
The lipid lowering effect of anagliptin in type2 diabetes mellitus with dyslipidemiaType2 diabetes mellitus patients with dyslipidemiaJPRN-UMIN000013682Internal Medicine, Teikyo University School of Medicine40